Screener
Charles River Laboratories CRL Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashCurrent.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | June 28, 2025 |
|---|---|---|
| Supplemental cash flow information: | ||
| Cash and cash equivalents | $192,025 | $182,824 |
| Restricted cash included in Other current assets | 24,427 | 398 |
| Restricted cash included in Other assets | 24,129 | 1,518 |
| Cash, cash equivalents, and restricted cash, end of period | $240,581 | $184,740 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's restricted cash?
- Charles River Laboratories (CRL) reported restricted cash of $24.43M in Q2 2026.
- How has Charles River Laboratories's restricted cash changed year-over-year?
- Charles River Laboratories's restricted cash increased by 6037.4% year-over-year, from $398K to $24.43M.
- What is the long-term trend for Charles River Laboratories's restricted cash?
- Over 4 years (2020 to 2025), Charles River Laboratories's restricted cash has grown at a -15.6% compound annual growth rate (CAGR), from $3.07M to $1.56M.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Charles River Laboratories's restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude